1. Home
  2. CTRE vs PRAX Comparison

CTRE vs PRAX Comparison

Compare CTRE & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareTrust REIT Inc.

CTRE

CareTrust REIT Inc.

N/A

Current Price

$40.00

Market Cap

8.2B

Sector

Real Estate

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$308.01

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTRE
PRAX
Founded
2013
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.6B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
CTRE
PRAX
Price
$40.00
$308.01
Analyst Decision
Buy
Strong Buy
Analyst Count
9
15
Target Price
$42.33
$572.13
AVG Volume (30 Days)
1.8M
331.9K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
3.35%
N/A
EPS Growth
96.25
N/A
EPS
1.57
N/A
Revenue
$476,393,000.00
N/A
Revenue This Year
$5.26
N/A
Revenue Next Year
$15.80
$6,395.88
P/E Ratio
$25.37
N/A
Revenue Growth
60.79
N/A
52 Week Low
$25.67
$26.70
52 Week High
$41.72
$354.87

Technical Indicators

Market Signals
Indicator
CTRE
PRAX
Relative Strength Index (RSI) 55.18 43.37
Support Level $33.44 $290.36
Resistance Level $41.54 $322.32
Average True Range (ATR) 0.80 19.36
MACD -0.18 -4.96
Stochastic Oscillator 44.89 26.43

Price Performance

Historical Comparison
CTRE
PRAX

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: